Filter
2886
Filtered Results: 2886
Text search:
tb
research
Featured
Recommendations
236
New Publications
822
Language
Document type
No document type
1918
Studies & Reports
438
Guidelines
268
Manuals
92
Strategic & Response Plan
85
Training Material
31
Fact sheets
27
Situation Updates
14
Infographics
8
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
India
142
Kenya
113
South Africa
90
Global
87
Western and Central Europe
78
Uganda
74
Ethiopia
70
Zambia
64
Malawi
62
Tanzania
60
Africa
57
Nepal
56
Nigeria
56
Liberia
47
Sierra Leone
44
Eastern Europe
44
Bangladesh
43
Ghana
42
Myanmar / Burma
40
Rwanda
38
Namibia
37
Lesotho
33
Ukraine
30
Cambodia
28
Asia
28
Zimbabwe
27
Latin America and the Carribbean
25
Philippines
24
South–East Asia Region
24
Botswana
20
Russia
18
Indonesia
17
Mozambique
15
Senegal
14
Colombia
13
East and Southern Africa
13
Eswatini/ Swaziland
12
Benin
11
Haiti
11
Congo, Democratic Republic of
11
Pakistan
11
Syria
10
Burkina Faso
10
Germany
10
West and Central Africa
10
Argentina
9
Middle East and North Africa
8
Vietnam
8
South Sudan
8
Tajikistan
7
Guinea
7
Brazil
7
Georgia
7
Cameroon
6
Peru
6
Southern Africa
6
Thailand
5
Albania
5
Armenia
5
Sudan
5
Timor Leste/ East Timor
4
Iran
4
Laos
4
Afghanistan
4
Venezuela
4
Jordan
4
Western Pacific Region
4
Lebanon
4
Papua New Guinea
4
Angola
4
El Salvador
3
USA
3
Eastern Europe and Central Asia
3
Moldova
3
Sri Lanka
3
Yemen
3
Iraq
3
Ecuador
3
North Macedonia
2
China
2
Estonia
2
Saudi Arabia
2
Paraguay
2
North America
2
Central African Republic
2
Poland
2
Bhutan
2
Somalia
2
North Korea
1
Serbia
1
Gambia
1
Singapore
1
Morocco
1
Qatar
1
Guinea-Bissau
1
Croatia
1
Hungary
1
Ireland
1
Gabon
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Chad
1
Libya
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1255
Clinical Guidelines
212
Public Health
122
Women & Child Health
86
Key Resources
56
Pharmacy & Technologies
35
Capacity Building
33
Annual Report MEDBOX
3
Toolboxes
TB
567
HIV
403
AMR
117
COVID-19
93
Mental Health
89
NTDs
60
Caregiver
58
Disability
42
Global Health Education
42
NCDs
41
Pharmacy
37
Ebola
35
Health Financing Toolbox
34
Refugee
28
Planetary Health
28
Rapid Response
22
Conflict
21
Polio
18
Natural Hazards
14
Social Ethics
8
Specific Hazards
4
Cholera
4
Zika
4
South Sudan
1
Health Financing
1
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Depression Research and Treatment
Volume 2012, Article ID 962860, 8 pages
doi:10.1155/2012/962860
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
This document is an evidence-based policy for the implementation of sound tuberculosis (TB) infection control by all stake- holders. It recommends a combination of measures aimed at reducing the risk of TB transmission within populations. The emphasis is on early and rapid diagnosis, and proper mana...
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)...
